Records containing: Myeloproliferative Diseases
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2025-11-04Investigation of the Genetics of Hematologic Diseases
-
CLINICAL_TRIALS study record update · 2024-12-10Production and Expansion of Chimeric Antigen Receptor (CAR)-Natural Killer (NK) Cells From Patients Affected by Lympho or Myeloproliferative Disorders and From Healthy Donors
-
CLINICAL_TRIALS study record update · 2023-06-29Phase II Study of Timed Sequential Busulfan in Combination With Fludarabine in Allogeneic Stem Cell Transplantation
-
CLINICAL_TRIALS study record update · 2019-12-03A Phase IIA Study of the Histone-deacetylase Inhibitor ITF2357 in Patients With JAK-2 V617F Positive Chronic Myeloproliferative Diseases
-
CLINICAL_TRIALS study record update · 2019-07-31Evaluation of Ruxolitinib and Lenalidomide Combination as a Therapy for Patients With Myelofibrosis
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2019-07-16A Phase 1/2 Trial Evaluating Treatment of Emergent Graft Versus Host Disease (GvHD) With AP1903 After Planned Donor Infusions (DLIs) of T-cells Genetically Modified With the iCasp9 Suicide Gene in Patients With Hematologic Malignancies
-
CLINICAL_TRIALS study record update · 2019-06-05Evaluation of Ruxolitinib and Pracinostat Combination as a Therapy for Patients With Myelofibrosis
-
CLINICAL_TRIALS study record update · 2018-10-05Pacritinib Prior to Transplant for Patients With Myeloproliferative Neoplasms (MPN)
-
CLINICAL_TRIALS study record update · 2018-05-31Clofarabine Plus Low-Dose Cytarabine for the Treatment of Patients With Higher-Risk Myelodysplastic Syndrome (MDS) Who Have Been Relapsing After, or Are Refractory to, Hypomethylator Therapy
-
CLINICAL_TRIALS study record update · 2016-03-17Phase 2 Study of Planned Donor Lymphocyte Infusion After Reduced Intensity Allogeneic Stem Cell Transplantation
-
CLINICAL_TRIALS study record update · 2012-11-09Non-Myeloablative Allogeneic Stem Cell Transplantation With Matched Unrelated Donors for Treatment of Hematologic Malignancies, Renal Cell Carcinoma, and Aplastic Anemia